Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.
W YacoubN WillietL PouillonT Di-BernadoM De Carvalho BittencourtS NanceyAnthony LopezStephane PaulC ZallotXavier RoblinLaurent Peyrin BirouletPublished in: Alimentary pharmacology & therapeutics (2018)
Early therapeutic drug monitoring might improve timely detection of vedolizumab-treated patients in need for an intensified dosing regimen.